These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9918898)
1. Increased splanchnic blood flow after hypoglycaemia in diabetic and normal man: evidence against glucagon as a mediator. Parker DR; Bargiota A; Braatvedt GD; Halliwell M; Corrall RJ Clin Sci (Lond); 1999 Feb; 96(2):179-84. PubMed ID: 9918898 [TBL] [Abstract][Full Text] [Related]
2. Evidence against a putative role for glucagon as a physiological splanchnic vasodilator in man. Braatvedt GD; Stanners A; Newrick PG; Halliwell M; Corrall RJ Clin Sci (Lond); 1993 Feb; 84(2):193-9. PubMed ID: 8095006 [TBL] [Abstract][Full Text] [Related]
3. Physiological control of splanchnic blood flow by adrenaline: studies during acute hypoglycaemia in man. Parker DR; Braatvedt GD; Halliwell M; Corrall RJ Clin Sci (Lond); 1999 Jun; 96(6):623-9. PubMed ID: 10334968 [TBL] [Abstract][Full Text] [Related]
4. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes. Sjöberg S; Ahrén B; Bolinder J J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607 [TBL] [Abstract][Full Text] [Related]
6. Protein and glutamine kinetics during counter-regulatory failure in type 1 diabetes. Battezzati A; Benedini S; Sereni LP; DeTaddeo F; Maffi P; Secchi A; Luzi L Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):352-7. PubMed ID: 18693094 [TBL] [Abstract][Full Text] [Related]
7. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672 [TBL] [Abstract][Full Text] [Related]
8. Impaired cutaneous reactive hyperaemia during hypoglycaemia in young insulin-dependent diabetic patients and healthy controls. Aman J; Berne C; Ewald U; Tuvemo T Acta Diabetol; 1992; 29(1):25-8. PubMed ID: 1520902 [TBL] [Abstract][Full Text] [Related]
9. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia. Hvidberg A; Christensen NJ; Hilsted J Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120 [TBL] [Abstract][Full Text] [Related]
10. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin. Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093 [TBL] [Abstract][Full Text] [Related]
11. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. Wahren J; Sato Y; Ostman J; Hagenfeldt L; Felig P J Clin Invest; 1984 May; 73(5):1367-76. PubMed ID: 6715541 [TBL] [Abstract][Full Text] [Related]
12. Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes. Lager I; von Schenck H; Smith U Diabetologia; 1984 May; 26(5):337-42. PubMed ID: 6376242 [TBL] [Abstract][Full Text] [Related]
13. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients. Oskarsson PR; Lins PE; Backman L; Adamson UC Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326 [TBL] [Abstract][Full Text] [Related]
14. Changes in brainstem auditory evoked potentials during insulin-induced hypoglycaemia in type 1 diabetic patients. Ziegler D; Hübinger A; Gries FA Diabet Med; 1991 Nov; 8(9):805-11. PubMed ID: 1837506 [TBL] [Abstract][Full Text] [Related]
15. Glucagon is absorbed from the rectum but does not hasten recovery from hypoglycaemia in patients with type 1 diabetes. Parker DR; Braatvedt GD; Bargiota A; Newrick PG; Brown S; Gamble G; Corrall RJ Br J Clin Pharmacol; 2008 Jul; 66(1):43-9. PubMed ID: 18507661 [TBL] [Abstract][Full Text] [Related]
16. Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state. Fanelli CG; Pampanelli S; Porcellati F; Bartocci L; Scionti L; Rossetti P; Bolli GB Diabetologia; 2003 Jan; 46(1):53-64. PubMed ID: 12637983 [TBL] [Abstract][Full Text] [Related]
17. Human insulin and awareness of acute hypoglycaemic symptoms in insulin-dependent diabetes. Patrick AW; Bodmer CW; Tieszen KL; White MC; Williams G Lancet; 1991 Aug; 338(8766):528-32. PubMed ID: 1678798 [TBL] [Abstract][Full Text] [Related]
18. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients. Lunetta M; Di Mauro M; Le Moli R; Nicoletti F Diabetes Metab; 1997 Dec; 23(6):524-7. PubMed ID: 9496559 [TBL] [Abstract][Full Text] [Related]
19. Regional variation in skin blood flow response to hypoglycaemia in type 1 (insulin-dependent) diabetic patients without complications. Wiles PG; Grant PJ; Stickland MH; Dean HG; Wales JK; Davies JA Diabetologia; 1988 Feb; 31(2):98-102. PubMed ID: 3282956 [TBL] [Abstract][Full Text] [Related]